glp-1 obesity injector components How diabesity is shaping the world of self-injection devices DELIVERING ON GLP-1 DEMAND: A

Whether youre taking Ozempic or another option in this class of medications, these prescriptions work by improving insulin sensitivity, slowing down your digestion, reducing your appetite, and helping with blood sugar management

Phase 2 orforglipron data demonstrated 14.7% body weight reduction at 45mg without food or water requirements, and the addressable patient expansion is estimated to grow the anti-obesity medication market by 180 million new prescription patients between 2027 and 2032

The standard pharmacokinetic rule is 4-5 half-lives for steady state

- **Curb appetite:** Helping individuals feel full, potentially leading to reduced food intake

According to the companys published outcomes, members lose an average of 15%19% of their body weight over one to three years

Stratifying patients into high and low GLP-1R expression groups based on the median expression level revealed a positive correlation between high GLP-1R expression and non-responsiveness to therapy (r=0.8718